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NATIONAL CANCER STRATEGY 2017-2026
Key Performance Indicators: December 2018
# Objective/Action Performance Indicator Target Target Date  End 2018 Position
1 Reduce the proportion of adults in the population who smoke percentage of adults (aged 15+) in population 
smoking daily
5% 2025 (interim 
17% by 2018)
17% (Healthy Ireland)
2 Introduce cancer awareness campaigns for specific diseases 
(e.g. Lung Cancer)
Percentage of lung cancers diagnosed at Stage I 
and II one year following awareness campaign
15% relative 
increase
One year after 
awareness 
campaign
The NCCP has conducted an evidence 
review in conjunction with the National 
Cancer Registry.
A population survey to inform the direction 
of the initial awareness campaign will take 
place in Spring 2019 with a view to 
launching the campaign in early 2020.
3 Expand electronic referrals for all GP cancer referrals Percentage of GP referrals received electronically 95% End 2022 
(interim 75% by 
end 2019)
66% (NCCP)
4 Increase proportion of cancers diagnosed early Percentage of colorectal, breast, and lung cancers 
diagnosed at Stage I and II
10% relative 
increase on 
2013 figures
2020 Baseline Figure (2014):
Colorectal:39%
Breast: 81%
Lung: 29%
(Most recent figures - NCRI)
5 Ensure Rapid Access Clinic and Symptomatic Breast Disease 
Clinic targets are met
Perecentage of new patients attending RAC or 
SBD clinic within timeframe
95% 2017 Figures Jan-Nov 2018:
Breast: 74.4%
Lung: 87.7%
Prostate: 77.2%
(HSE)
6 Ensure GPs have direct access to diagnostics for patients 
meeting referral criteria
Percentage of patients accessing 
imaging/diagnostics/endoscopy within agreed 
timelines
90% 2020
Early stage of development.
7 Reduce the proportion of cancers detected in Emergency 
Departments
Percentage of cancers diagnosed in Emergency 
Departments
50% relative 
decrease over 
2013 figure
2026 Baseline Figure 2013: 13.7%
 2016: 13.3% 
(NCRI)
8 Maintain target uptake rate for BreastCheck Percentage uptake rate for BreastCheck screening 
population
70% 2017-2026 76.2% (Jan-Jun 2018)
(NSS)
9 Achieve target coverage rate for CervicalCheck Percentage five year rolling coverage of 
CervicalCheck in screening population
80% 2017-2026 79.8% (Jan-Jun 2018)
(NSS)
10 Achieve target uptake rate for BowelScreen Percentage uptake rate for BowelScreen 
screening population
60% 2020 (interim 
measure of 45% 
by end 2018)
41.1% (Jan-Jun 2018)
(NSS)
11 Complete centralisation of cancer surgical services Percentage of surgeries conducted in approved 
centres
95% Various target 
dates to 2020
83%
(NCCP)
12 Ensure that patients have their case discussed at an MDT 
meeting
Percentage of patients diagnosed with invasive 
cancers formally discussed at MDT meetings
95% End 2020 Figures for Breast, lung, prostate and rectal 
cancers (Jan-Jun 2018):
92% (NCCP)
13 Ensure that patients on active treatment receive appropriate 
admission in emergency situations
Percentage of patients on active cancer treatment 
admitted to hospital for cancer treatment that are 
admitted through Emergency Departments.
Less than 20% 2018
Working with the NCR and the NCCP to 
ascertain how the data can best be 
captured.
14 Ensure patients with cancer are admitted to cancer units Percentage of patients requiring active treatment 
for their cancer admitted to dedicated cancer 
units in hospitals
80% 2020 Working with the NCR and the NCCP to 
ascertain how the data can best be 
captured.
15 Reduce waiting times for surgery Percentage of patients seen within NCCP target 
surgery timeframes for defined cancers
90% 2017
Breast, lung, prostate, pancreas and upper 
gastro-intestinal cancers 
(Jan-Jun 2018): 70% (NCCP)
16 Achieve the radiotherapy treatment target Percentage of patients commencing treatment 
within 15 working days of being deemed ready to 
treat
90% 2017
82.1% (Jan-Nov 2018)
(HSE)
17 Offer patients with cancer a Treatment Summary and Care 
Plan
Percentage of patients receiving a Treatment 
Summary and Care Plan
95% 2020; interim 
target 50% by 
2018
Working with the NCCP and the designated 
cancer centres to ascertain how the data 
can best be captured.
18 Avoid chemotherapy in patients with advanced cancer who 
are unlikely to benefit as they are in the terminal phase of 
their disease
Percentage of patients with metastatic cancer 
given chemotherapy in last month of life
Less than 25% 2019
Working with the NCCP to ascertain how 
the data can best be captured.
19 Increase proportion of patients receiving specialist palliative 
care
Percentage of patients with cancer with Stage IV 
disease receiving specialist palliative care
90% 2019
Working with the HSE to ascertain how the 
data can best be captured.
20 Increase patient participation in clinical trials Percentage of patients on cancer therapeutic 
clinical trials
6% 2020 3% 
(CTI)
21 Improve Ireland's cancer ranking among EU member states Ireland to be in top quartile for five year survival 
among EU member states
Top Quartile 
for overall 
survival
2026 OECD Health at a Glance 2018
5-Year Survival 2010-2014:
Cervical (63.6%) - 16th of 24
Breast (82%) - 15th of 24
Colon (60.5%) - 13th of 23
Rectal (61.7%) - 9th of 24
22 Reduce inequalities in age standardised cancer incidence for 
all malignant neoplasms (excl. NMSC)
Comparison between bottom 20% deprivation vs. 
top 20%
Difference no 
greater than 
3%
2026 Incidence is 7.1%  higher in most-deprived 
20% compared to least deprived 20% (2008-
2012)
(NCRI)
23 Reduce inequalities in five year survival for: all cancers 
combined (excl. NMSC); colorectal; lung; and breast.
Comparison between bottom 20% deprivation vs. 
top 20%
Difference no 
greater than 
3%
2026 Survival is 8.9 %  lower in most-deprived 
20% compared to least deprived 20% (2009-
2013)
(NCRI)
